JQ1 is a potent competitive inhibitor of acetylation of lysine residues for BET, and it was initially proven to be effective in nuclear protein in testis (NUT) midline carcinoma (NMC), a cancer driven by the BRD4-NUT fusion protein18. The gene discussed is BRD4; the disease is nut midline carcinoma.